Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2025-01-24 00:00:00 ET · period of report 2025-01-23 · accession 0000950170-25-008909 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-24 | 2025-01-23 | WVE | Vargeese Chandra | See Remarks | M - OptEx | $2.48 | +46.0K | 233.9K | +24% | +$114.1K |
| D | 2025-01-24 | 2025-01-23 | WVE | Vargeese Chandra | See Remarks | M - OptEx | $0.00 | -46.0K | 16.4K | -74% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-01-23 | M | A | 46,000 | $2.48 | 233,933 | D | — | — | (F1) Includes 2,872 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan. |
| 2 | Derivative | Share Option (right to buy) | 2025-01-23 | M | D | 46,000 | $0.00 | 16,422 | D | $2.48 · — to 2025-03-10 | 46,000 Ordinary Shares | (F2) The share options that were exercised via cash purchase in this reportable transaction were fully vested. |